1. Academic Validation
  2. AMPK activation alleviated DSS-induced colitis by inhibiting ferroptosis

AMPK activation alleviated DSS-induced colitis by inhibiting ferroptosis

  • J Dig Dis. 2023 May 20. doi: 10.1111/1751-2980.13176.
Shaopeng Sun 1 Yifan Lu 1 Heng Li 1 Chunyan Weng 1 Jiajia Chen 2 Yijie Lou 1 Dong Lv 1 Bin Lv 3
Affiliations

Affiliations

  • 1 The First Clinical Medical College of Zhejiang Chinese Medical University.
  • 2 Department of Anesthesiology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine).
  • 3 Department of Gastroenterology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine).
Abstract

Objective: Ferroptosis is a newly discovered cell death mode that has been confirmed to occur in ulcerative colitis (UC) intestinal epithelial cells. Therefore, it is particularly important to find key targets to block Ferroptosis.

Methods: Human colon samples and animal models were used in this study. The Ferroptosis related protein in human colon tissue was detected by immunohistochemistry. The clinical symptoms, iron abundance and lipid peroxidation level of experimental mice were measured to evaluate the role of AMPK activation in reversing Ferroptosis.

Results: We verified the expression difference of ferroptosis-related genes and proteins between UC patients and healthy people. Besides, we also confirmed the occurrence of colonic Ferroptosis in a DSS-induced mouse model. Activation of AMPK inhibits Ferroptosis in the colon, improves symptoms and prolongs lifespan in DSS-induced colitis mice.

Conclusion: Collectively, our results illustrated that AMPK may be an important target for the inhibition of Ferroptosis, which provides a potential therapeutic strategy for colitis.

Keywords

AMPK; Dextran sulfate sodium; Ferroptosis; Metformin; Ulcerative colitis.

Figures
Products